Development of a multi-epitope mRNA vaccine targeting tumor-associated antigens for esophageal squamous cell carcinoma
Henghui Zhang, Hao Liang, Tingting Dai, Ning Shen, Chenlu Liu, Yang Zhou, Zhenhua Wei, Zhongqiu Wu, Pengfei Yu, Quan Zhang, Xiaona Zhang, Jinxuan Yu, Xuefeng Ji, Airong Yang, Cuiping An, Ying Han, Xi Jiao, Lu Qian, Zhihao Lu · 2026
Read Development of a multi-epitope mRNA vaccine targeting tumor-associated antigens for esophageal squamous cell carcinoma by Henghui Zhang, Hao Liang, Tingting Dai, Ning Shen, Chenlu Liu, Yang Zhou, Zhenhua Wei, Zhongqiu Wu, Pengfei Yu, Quan Zhang, Xiaona Zhang, Jinxuan Yu, Xuefeng Ji, Airong Yang, Cuiping An, Ying Han, Xi Jiao, Lu Qian, Zhihao Lu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13639008.txt.
Description
Henghui Zhang and eighteen colleagues present a 2026 preclinical study of an mRNA vaccine for esophageal squamous cell carcinoma, a cancer with few options once immunotherapy stops working. The vaccine, called IPM514, carries pieces of proteins commonly found on these tumors.
Its fifteen fragments come from nine tumor antigens chosen from large datasets and checked in samples from 132 patients. In cell tests the vaccine expanded T cells that killed cancer cells, and in mice it slowed tumors and extended survival. Adding a PD-1 blocking drug strengthened the effect. The authors propose the vaccine as a new immunotherapy strategy.
Catalog record
| CREATOR | Henghui Zhang, Hao Liang, Tingting Dai, Ning Shen, Chenlu Liu, Yang Zhou, Zhenhua Wei, Zhongqiu Wu, Pengfei Yu, Quan Zhang, Xiaona Zhang, Jinxuan Yu, Xuefeng Ji, Airong Yang, Cuiping An, Ying Han, Xi Jiao, Lu Qian, Zhihao Lu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72889 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |